Latest Revenue Growth News

Starpharma reports a 165% rise in FY25 customer receipts, advances its clinical-stage DEP® assets, and secures new distribution deals in Asia and Saudi Arabia.

Hydrix Limited reports steady June quarter revenues with a 10% rise from the prior quarter, supported by new contract wins and a robust $40 million project pipeline.

Airtasker Limited has reported its second consecutive year of positive free cash flow alongside robust revenue growth, fueling accelerated expansion in the UK and US marketplaces.

Mad Paws Holding Limited reported modest revenue growth and improved cash flow in Q4 2025, while progressing a significant acquisition deal with Rover Group and divesting its Pet Chemist business.

MedAdvisor Solutions reported a 16.6% revenue decline in 4Q FY25, driven by US market challenges, while completing the sale of its ANZ business and initiating a strategic review of its US operations.

Airtasker Limited reports its second consecutive year of positive free cash flow alongside a 29% jump in marketplaces revenue, driven by explosive growth in the UK and US markets.

MedAdvisor reports a significant revenue decline in FY25 amid US program delays but strengthens its balance sheet through a capital raise and ANZ business sale. The company signals a strategic pivot with potential US business divestment on the horizon.

Decidr AI Industries reported an 82% revenue jump in its AI platform during Q4 FY25, launched AI Mentors with The Growth Faculty, and divested its 13Seeds business to sharpen focus on AI innovation.

Cluey Ltd has achieved its first-ever positive operating cash flow in Q4 FY25, marking a pivotal shift towards sustainable growth powered by AI innovation and expanded market reach.

Control Bionics capped a record FY25 with 15% revenue growth, driven by US market gains and expanding NeuroNode and NeuroStrip technologies. The company also achieved a US profitability milestone and is close to finalizing key distribution partnerships.

Osteopore Limited has posted a record AUD 835K revenue in Q2 CY25, driven by strong APAC sales and new European market access following EU MDR clearance. The company also advances clinical trials and refreshes key distribution channels.

Stakk Limited has reported a remarkable 262% year-on-year increase in annual recurring revenue receipts, driven by its Embedded Finance services in the US and Australia. The company is poised to broaden its offerings with new client wins and the upcoming launch of Embedded Lending capabilities.